GlaxoSmithKline Has New Country Head For Its Philippine Operation
GlaxoSmithKline (GSK) Asia Pacific Senior Vice President & Regional Director Venkatraman Thyagarajan is pleased to announce the appointment of Rick T. Gain as the new President & Managing Director for its Philippine operation.
GlaxoSmithKline’s Cainta plant sets safety benchmarks
GlaxoSmithKline’s GMS-Cainta has announced a recorded one million consecutive manhours without Lost Time Injury/Illness (LTII) in its manufacturing plant located at Don Celso Tuason Avenue, Cainta, Rizal as of June 2006. The Cainta facility, which is operated by 200 employees and contractors, handles the manufacturing and packaging of GSK’s pharmaceutical and consumer healthcare products.
More articles
GlaxoSmithKline encourages employees to help preserve the environment
Earth Week is regularly celebrated globally to remind people to conserve the planet’s resources and protect the only home we have. GlaxoSmithKline (GSK) commemorated this year’s Earth Week through a series of lectures and events aimed to promote environmental awareness toward its employees, contractors and their families. This was part of the company’s global initiative to promote environmental conservation.
More about the environment
Our products
Our pharmaceutical products include treatments for asthma, bacterial infection, depression, migraine, diabetes, heart failure and digestive conditions.
We also market vaccines to protect against illnesses such as influenza, rotavirus, hepatitis A and B, diphtheria, tetanus, typhoid, chicken pox and meningoccimia.
We bring dental health products and over-the-counter medicines to millions of Filipinos like Astring O Sol, Sensodyne, Aquafresh, Calpol and Dequadin.
